Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors
期剂量扩展和生物标志物研究评估了首创肿瘤微环境调节剂 VT1021 对晚期实体瘤患者的疗效
期刊:Commun Med (Lond)
影响因子:
doi:10.1038/s43856-024-00520-z
Jian Jenny Chen, Melanie Y Vincent, Dale Shepard, David Peereboom, Devalingam Mahalingam, James Battiste, Manish R Patel, Dejan Juric, Patrick Y Wen, Andrea Bullock, Jennifer Eva Selfridge, Shubham Pant, Joyce Liu, Wendy Li, Susanne Fyfe, Suming Wang, Victor Zota, James Mahoney, Randolph S Watnick,
